Literature DB >> 9650955

Comparison of Roche Cobas Amplicor Mycobacterium tuberculosis assay with in-house PCR and culture for detection of M. tuberculosis.

B R Eing1, A Becker, A Sohns, R Ringelmann.   

Abstract

The new Roche Cobas Amplicor Mycobacterium tuberculosis assay, which is a semiautomated version of the manually performed Roche Amplicor M. tuberculosis test, was compared to culture and an IS6110-based in-house PCR protocol. A total of 1,681 specimens from 833 patients, including specimen types other than sputum, were tested in parallel by both the in-house PCR and the Cobas Amplicor M. tuberculosis assay. After we resolved discrepant PCR results, the sensitivity, specificity, and positive and negative predictive values for the Cobas Amplicor M. tuberculosis assay were 66.33, 99.71, 94.36, and 97.66%, respectively. The corresponding values for the in-house PCR were 91.08, 99.85, 97.87, and 99.37%, respectively. For culture- and smear-positive specimens, the sensitivity of the Cobas Amplicor M. tuberculosis test was 96.42% (in-house PCR, 100%). If only smear-negative sputum specimens were considered, the Cobas Amplicor M. tuberculosis assay exhibited a sensitivity of 45.45% (in-house PCR, 63.63%) relative to that of culture. With a modified protocol for DNA extraction (washing of samples plus ultrasonication), both PCR methods performed better with gastric aspirates than with sputum samples (sensitivity of the Cobas Amplicor M. tuberculosis assay with smear-negative gastric aspirates, 70.00%; sensitivity of in-house PCR, 90.00%). With dithiothreitol being used for liquefaction of specimens in this study, the Cobas Amplicor M. tuberculosis assay exhibited an inhibition rate of 9.16%. In our view, the new Cobas Amplicor M. tuberculosis test (i) is well suited for typing of smear-positive specimens, (ii) may also be applied to gastric aspirates and other types of specimens if DNA extraction methods are modified appropriately, and (iii) exhibits a sensitivity with smear-negative sputum specimens which makes it recommendable that a minimum of three samples from the same patient be tested.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9650955      PMCID: PMC104971     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  26 in total

1.  Rapid identification of mycobacteria to the species level by polymerase chain reaction and restriction enzyme analysis.

Authors:  A Telenti; F Marchesi; M Balz; F Bally; E C Böttger; T Bodmer
Journal:  J Clin Microbiol       Date:  1993-02       Impact factor: 5.948

2.  Detection of Mycobacterium tuberculosis in clinical specimens by polymerase chain reaction and Gen-Probe Amplified Mycobacterium Tuberculosis Direct Test.

Authors:  C Abe; K Hirano; M Wada; Y Kazumi; M Takahashi; Y Fukasawa; T Yoshimura; C Miyagi; S Goto
Journal:  J Clin Microbiol       Date:  1993-12       Impact factor: 5.948

3.  Detection of Mycobacterium tuberculosis in sputum samples using a polymerase chain reaction.

Authors:  K D Eisenach; M D Sifford; M D Cave; J H Bates; J T Crawford
Journal:  Am Rev Respir Dis       Date:  1991-11

4.  Direct detection of Mycobacterium tuberculosis complex in respiratory specimens by a target-amplified test system.

Authors:  G E Pfyffer; P Kissling; R Wirth; R Weber
Journal:  J Clin Microbiol       Date:  1994-04       Impact factor: 5.948

5.  Large-scale use of polymerase chain reaction for detection of Mycobacterium tuberculosis in a routine mycobacteriology laboratory.

Authors:  J E Clarridge; R M Shawar; T M Shinnick; B B Plikaytis
Journal:  J Clin Microbiol       Date:  1993-08       Impact factor: 5.948

6.  Evaluation of Amplicor PCR for direct detection of Mycobacterium tuberculosis from sputum specimens.

Authors:  K G Beavis; M B Lichty; D L Jungkind; O Giger
Journal:  J Clin Microbiol       Date:  1995-10       Impact factor: 5.948

7.  Detection and identification of Mycobacterium tuberculosis directly from sputum sediments by Amplicor PCR.

Authors:  D F Moore; J I Curry
Journal:  J Clin Microbiol       Date:  1995-10       Impact factor: 5.948

8.  Rapid diagnosis of pulmonary tuberculosis by using Roche AMPLICOR Mycobacterium tuberculosis PCR test.

Authors:  R F D'Amato; A A Wallman; L H Hochstein; P M Colaninno; M Scardamaglia; E Ardila; M Ghouri; K Kim; R C Patel; A Miller
Journal:  J Clin Microbiol       Date:  1995-07       Impact factor: 5.948

9.  Q-beta replicase-amplified assay for detection of Mycobacterium tuberculosis directly from clinical specimens.

Authors:  J S Shah; J Liu; D Buxton; A Hendricks; L Robinson; G Radcliffe; W King; D Lane; D M Olive; J D Klinger
Journal:  J Clin Microbiol       Date:  1995-06       Impact factor: 5.948

10.  Utility of PCR in diagnosing pulmonary tuberculosis.

Authors:  J Bennedsen; V O Thomsen; G E Pfyffer; G Funke; K Feldmann; A Beneke; P A Jenkins; M Hegginbothom; A Fahr; M Hengstler; G Cleator; P Klapper; E G Wilkins
Journal:  J Clin Microbiol       Date:  1996-06       Impact factor: 5.948

View more
  29 in total

Review 1.  Modern laboratory diagnosis of mycobacterial infections.

Authors:  S A Watterson; F A Drobniewski
Journal:  J Clin Pathol       Date:  2000-10       Impact factor: 3.411

2.  Removal of PCR inhibitors by silica membranes: evaluating the Amplicor Mycobacterium tuberculosis kit.

Authors:  B Böddinghaus; T A Wichelhaus; V Brade; T Bittner
Journal:  J Clin Microbiol       Date:  2001-10       Impact factor: 5.948

Review 3.  Relevance of commercial amplification methods for direct detection of Mycobacterium tuberculosis complex in clinical samples.

Authors:  Claudio Piersimoni; Claudio Scarparo
Journal:  J Clin Microbiol       Date:  2003-12       Impact factor: 5.948

4.  Performance assessment of a novel two-step multiple displacement amplification-PCR assay for detection of Mycobacterium tuberculosis complex in sputum specimens.

Authors:  Na Wu; Yuanyuan Zhang; Jun Fu; Ruifen Zhang; Lan Feng; Yongfei Hu; Xiaoliang Li; Na Lu; Xiuqin Zhao; Yuanlong Pan; Jing Li; Baoli Zhu; Kanglin Wan
Journal:  J Clin Microbiol       Date:  2012-01-18       Impact factor: 5.948

5.  Comparison of two molecular methods for rapid diagnosis of extrapulmonary tuberculosis.

Authors:  Manuel Causse; Pilar Ruiz; Juan Bautista Gutiérrez-Aroca; Manuel Casal
Journal:  J Clin Microbiol       Date:  2011-06-08       Impact factor: 5.948

6.  Comparison of amplicor and GeneXpert MTB/RIF tests for diagnosis of tuberculous meningitis.

Authors:  Vinod B Patel; Cathy Connolly; Ravesh Singh; Laura Lenders; Brian Matinyenya; Grant Theron; Thumbi Ndung'u; Keertan Dheda
Journal:  J Clin Microbiol       Date:  2014-07-23       Impact factor: 5.948

7.  Comparison of enhanced Mycobacterium tuberculosis amplified direct test with COBAS AMPLICOR Mycobacterium tuberculosis assay for direct detection of Mycobacterium tuberculosis complex in respiratory and extrapulmonary specimens.

Authors:  C Scarparo; P Piccoli; A Rigon; G Ruggiero; M Scagnelli; C Piersimoni
Journal:  J Clin Microbiol       Date:  2000-04       Impact factor: 5.948

8.  Multicenter evaluation of the BACTEC MGIT 960 system for recovery of mycobacteria.

Authors:  B A Hanna; A Ebrahimzadeh; L B Elliott; M A Morgan; S M Novak; S Rusch-Gerdes; M Acio; D F Dunbar; T M Holmes; C H Rexer; C Savthyakumar; A M Vannier
Journal:  J Clin Microbiol       Date:  1999-03       Impact factor: 5.948

9.  Evaluation of Cobas TaqMan MTB for direct detection of the Mycobacterium tuberculosis complex in comparison with Cobas Amplicor MTB.

Authors:  Guido V Bloemberg; Antje Voit; Claudia Ritter; Vanessa Deggim; Erik C Böttger
Journal:  J Clin Microbiol       Date:  2013-04-24       Impact factor: 5.948

10.  Performance of an IS6110-based PCR assay and the COBAS AMPLICOR MTB PCR system for detection of Mycobacterium tuberculosis complex DNA in human lymph node samples.

Authors:  Dagmar Rimek; Sachin Tyagi; Reinhard Kappe
Journal:  J Clin Microbiol       Date:  2002-08       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.